替罗非班不同给药策略辅助PCI术对急性前壁心肌梗死患者心肌灌注水平、心电图改善情况及炎症因子水平的影响

doi:10.3969/j.issn.1671-7171.2022.05.015

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1157 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨替罗非班不同给药策略辅助经皮冠状动脉介入治疗(PCI)术对急性前壁心肌梗死患者心肌灌注水平、心电图改善情况及炎症因子水平的影响。【方法】回顾性分析西安高新医院收治的96例急性前壁心肌梗死患者的临床资料,根据治疗方法的不同将其分为观察组和对照组,每组48例。两组患者均给予冠脉血栓抽吸+PCI,对照组静脉滴注替罗非班,观察组经冠状动脉内导管注射替罗非班。比较两组患者术后即刻心肌灌注水平、心电图表现(2 h内ST段回落幅度及Tp-e/QT)、不良反应及主要不良心脏事件(MACE)发生率,比较手术前后心肌损伤指标[肌酸磷酸激酶同工酶(CK-MB)、肌钙蛋白I(cTnI)、脑钠肽(BNP)、乳酸脱氢酶(LDH)、肌酸激酶(CK)],炎症损伤指标[可溶性血管细胞间黏附分子-1(sVCAM-1)、可溶性CD40L(sCD40L)、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)]。【结果】观察组术后即刻心肌灌注水平改善情况优于对照组,观察组2 h内ST段回落良好率高于对照组(P<0.05);两组治疗后Tp-e/QT值均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。治疗后,两组血清CK-MB、cTnI、BNP、LDH、CK、sVCAM-1、sCD40L、CRP、TNF-α水平均低于治疗前,且观察组低于对照组(P<0.05)。两组患者不良反应及治疗后3个月MACE总发生率比较,差异无统计学意义(P>0.05)。【结论】经冠状动脉内导管注射替罗非班可显著改善经冠脉血栓抽吸+PCI术治疗的急性前壁心肌梗死患者心肌灌注水平,优化心电图表现,改善炎症因子水平,且安全性较好。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘艳
	白光明

关键词 ：前壁心肌梗死, 血管成形术,气囊,冠状动脉, 血小板糖蛋白GPⅡb-Ⅲa复合物/治疗应用, 心电描记术

Abstract：【Objective】 To explore effects of different administration strategies of tirofiban assisted PCI (percutaneous coronary intervention) on postoperative myocardial perfusion level, electrocardiogram performance, the incidence of major adverse cardiovascular events (MACE) and inflammatory factors such as soluble vascular cell adhesion molecule-1 (sVCAM-1) and platelet activating factor (PAF) in patients with of acute anterior myocardial infarction. 【Methods】 Clinical data of 96 patients with acute anterior myocardial infarction in Xi'an Gaoxin hospital were retrospectively analyzed and divided into the observation group and the control group by random number table, with 48 cases in each group. Both groups were given coronary thrombus aspiration and PCI. While the control group was given tirofiban intravenously and the observation group was given tirofiban catheter injection. Patients in the two groups were compared by myocardial perfusion level post-operation, ECG performance (ST-segment fall range and Tp-e/QT), adverse reactions and MACE incidence rates immediately after surgery, and myocardial injury indexes before and after surgery [creatine phosphokinase isoenzyme (CK-MB), troponin I (cTnI), brain natriuretic peptide (BNP), lactate dehydrogenase (LDH), creatine kinase (CK)], inflammatory injury indicators [sVCAM-1, soluble CD40L (sCD40L), C-reactive protein (CRP), tumor necrosis factor-α (TNF-α)].【Results】 The improvement of immediate myocardial perfusion in the observation group was better than that of the control group (P<0.05).The good rate of ST segment fall in the observation group within 2 hours was higher than that of the control group (P<0.05). The Tp-e/QT values of the two groups after treatment were lower than those before treatment; And value of Tp-e/QT in the observation group was lower than that in the control group (P<0.05). After treatment, CK-MB, cTnI, BNP, LDH, CK, sVCAM-1, sCD40L, CRP and TNF-α in the observation group were lower than those before treatment. And the levels of the observation group were lower than those of the control group (P<0.05). The difference in the total incidence of adverse reactions and MACE at 3 months after treatment in the two groups was not statistically significant (P>0.05). 【Conclusion】 Compared with tirofiban intravenous infusion, catheter injection of tirofiban can significantly improve myocardial perfusion in patients with coronary thrombus aspiration + PCI, optimize ECG performance and adjust sVCAM-1 and PAF levels, which has certain safety.

Key words： Anterior Wall Myocardial Infarction Angioplasty, Balloon, Coronary Platelet Glycoprotein GPⅡb-Ⅲa Complex/TU Electrocardiography

收稿日期: 2021-09-10

中图分类号:

R542.22

通讯作者: *E-mail:997439509@qq.com

引用本文:

刘艳, 白光明. 替罗非班不同给药策略辅助PCI术对急性前壁心肌梗死患者心肌灌注水平、心电图改善情况及炎症因子水平的影响[J]. 医学临床研究, 2022, 39(5): 693-696.
LIU Yan, BAI Guang-ming. Effects of Different Administration Strategies of Tirofiban Assisted PCI on Myocardial Perfusion Level, Electrocardiogram Performance and Inflammatory Factors in Patients with Acute Anterior Myocardial Infarction. JOURNAL OF CLINICAL RESEARCH, 2022, 39(5): 693-696.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2022.05.015 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2022/V39/I5/693

[1] NOVAK J E, HANDA R. Contrast nephropathy associated with percutaneous coronary angiography and intervention[J].Cardiol Clin,2019,37(3):287-296.
[2] 魏梅,郑明奇,刘刚,等.新活素对急性前壁心肌梗死急诊PCI病人心率变异性及心功能的影响[J].中西医结合心脑血管病杂志,2019,17(6):876-878.
[3] 中国医师协会急诊医师分会,中华医学会心血管病学分会,中华医学会检验医学分会,等.急性冠脉综合征急诊快速诊疗指南[J].中华急诊医学杂志,2016,25(4):397-404.
[4] 王骥飞,房超,杨光,等.STEMI患者炎症反应水平及罪犯斑块特征与PCI术前TIMI血流分级的关系[J].中华心血管病杂志,2021,49(2):150-157.
[5] 王芳,徐承义,刘心甜,等.左西孟旦在急性前壁心肌梗死合并心力衰竭患者中的应用[J].中国心血管杂志,2019,24(3):245-249.
[6] 王昆,李飞,康丽娜,等.急性前壁心肌梗死患者急诊PCI时联合冠状动脉内综合血栓减负的疗效[J].中国动脉硬化杂志,2019,27(7):599-605.
[7] 冯强,李作坤,张坡,等.不同剂量盐酸替罗非班联合PCI对急性心肌梗死的临床疗效研究[J].中国循证心血管医学杂志,2019,11(3):349-352.
[8] 孙江丽,张晓平.替罗非班不同给药途径联合血栓抽吸对急性ST段抬高型心肌梗死病人预后的影响:一项随机、对照、开放研究[J].安徽医药,2020,24(9):1850-1855.
[9] 中国心血管病相关专家小组.替罗非班在冠状动脉粥样硬化性心脏病治疗的中国专家共识[J].中华内科杂志,2013,52(5):434-439.
[10] Su Q,Li L,Sun Y,et al.Effects of the tlr4/myd88/nf-κb signaling pathway on nlrp3 inflammasome in coronary microembolization-induced myocardial injury[J].Cell Physiol Biochem,2018,47(4):1497-1508.
[11] 邱晓娜,马洪山,张萍,等.高血栓负荷ST段抬高型心肌梗死患者静脉内和冠状动脉内给予替罗非班对心肌组织灌注的比较研究[J].中国循环杂志,2019,34(1):50-54.